Our computational and experimental results suggest that TP53 mutations may alter immune activity in BC via regulation of the p53-mediated pathways, including cell cycle, apoptosis, Wnt, Jak-STAT, NOD-like receptor, and glycolysis. Here, TP53 is linked to breast cancer.